SQZ Biotechnologies Company (SQZB)
OTCMKTS: SQZB · Delayed Price · USD
0.0465
0.00 (0.00%)
Apr 23, 2024, 4:00 PM EDT - Market closed

SQZB Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20222021202020192018
Net Income
-79.46-68.74-50.52-32.2-20.23
Depreciation & Amortization
11.6811.0310.944.361.07
Share-Based Compensation
8.48.513.62.110.59
Other Operating Activities
-24.17-32.93-7.18-7.7538.69
Operating Cash Flow
-83.55-82.14-43.15-33.4921.1
Capital Expenditures
-0.49-0.61-1.18-2.17-1.31
Change in Investments
0059-10.68-35.66
Investing Cash Flow
-0.49-0.6157.82-12.85-36.96
Share Issuance / Repurchase
4.2357.8174.410.090.09
Other Financing Activities
--1.94225.9568.03
Financing Cash Flow
4.2355.91116.4226.0468.12
Net Cash Flow
-79.8-26.84131.09-20.352.26
Free Cash Flow
-84.04-82.75-44.33-35.6619.79
Free Cash Flow Margin
-391.27%-305.37%-211.11%-177.33%156.22%
Free Cash Flow Per Share
-2.92-3.00-8.21-20.9212.47
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).